EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE by K. B. Mirzaev, D. A. Andreev, D. A. Sychev

Get full text

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA by K. B. Mirzaev, D. A. Sychev, D. A. Andreev

Get full text

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population by K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev

Get full text

Choriodal melanoma: is enucleation still relevant? by A. F. Brovkina, K. B. Mirzaev, L. A. Kabardikova, N. D. Tsybikova

Get full text

THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev

Get full text

The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis by S. P. Abdullaev, K. B. Mirzaev, P. O. Bochkov, I. N. Sychev, D. A. Sychev

Get full text

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANE... by K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev

Get full text

Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case by M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov

Get full text

Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases by V. Yu. Pylev, A. T. Agdzhoyan, I. O. Gorin, V. S. Petrushenko, E. A. Pocheshkhova, K. B. Mirzaev, E. V. Balanovskaya

Get full text

Patients’ Pharmacogenetic Characteristics and the Risk of Adverse Reactions to Non-steroidal Anti-inflammatory Drugs: Case Reports by A. S. Zhiryakova, N. P. Denisenko, A. V. Kryukov, K. A. Akmalova, S. N. Tuchkova, K. B. Mirzaev, D. A. Sychev

Get full text

CYTOCHROME P450 (CYP2C9) ACTIVENESS, EVALUATED VIA LOSARTAN TEST, AS PREDICTION MARKER FOR THE WARFARIN TREATMENT DOSAGE CHOICE IN PATIENTS WITH DELAYED OUTCOMES AFTER HEART VALVES... by S. M. Arslanbekova, D. A. Sychev, K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, N. M. Magomedova, E. Z. Golukhova

Get full text

Clinical Signs and Medical History as Predictors of Enalapril-Associated Dry Cough in Cardiovascular Patients by I. V. Sychev, N. P. Denisenko, A. A. Kachanova, A. V. Lapshtaeva, Sh. P. Abdullaev, L. N. Goncharova, K. B. Mirzaev, D. A. Sychev

Get full text

NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME by K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev

Get full text

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease by N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev

Get full text

Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment by I. I. Temirbulatov, A. V. Kryukov, K. B. Mirzaev, N. P. Denisenko, S. P. Abdullaev, A. V. Petrova, E. P. Tkach, A. V. Shipacheva, D. A. Sychev

Get full text

Genogeographic technologies of a population biobank as a tool for assessing selection effects (using the example of pharmacogenetic biomarkers of cardiovascular diseases) by E. V. Balanovskaya, I. O. Gorin, G. Yu. Ponomarev, V. Yu. Pylev, R. O. Belov, E. A. Pocheshkhova, Sh. P. Abdullaev, K. B. Mirzaev, D. A. Sychev

Get full text

The Effect of Carriage of <i>CYP3A5*3</i> and <i>CYP3A4*22</i> Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19 by I. I. TEMIRBULATOV, A. V. KRYUKOV, K. B. MIRZAEV, N. P. DENISENKO, S. P. ABDULLAEV, A. S. ZHIRYAKOVA, Y. V. SHEVCHUK, V. I. VECHORKO, O. V. AVERKOV, D. A. SYCHEV

Get full text

Features of drug-drug interactions rivaroxaban and calcium channel blockers depending on the ABCB1 genotype (rs1045642 and rs4148738) in patients 80 years of age and older with non... by D. A. Sychev, K. B. Mirzaev, M. S. Cherniaeva, N. V. Shakhgildyan, Sh. P. Abdullaev, N. P. Denisenko, Zh. A. Sozaeva, A. A. Kachanova, V. R. Shastina, S. V. Gorbatenkova

Get full text

Pharmacogenetic aspects of the effectiveness of nonsteroidal anti-inflammatory drugs and opioids for postoperative pain management in patients after total joint arthroplasty by A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev

Get full text

Pharmacogenetic aspects of the efficacy of nonsteroidal anti-inflammatory drugs and opioid analgesics for postoperative pain relief after total joint arthroplasty by A. S. Zhiryakova, N. P. Denisenko, S. N. Tuchkova, A. S. Petrukhina, A. V. Kryukov, I. V. Sychev, K. B. Mirzaev, O. V. Averkov, V. I. Vechorko, E. O. Filatov, D. A. Sychev

Get full text